Loading...
Thumbnail Image
Item

Assessment and Treatment of Cutaneous Leishmaniasis in the Emergency Department

McGhee, Stephen
Angus, Neil
Finnegan, Alan
Lewis-Pierre, LaToya
Ortega, Johis
Citations
Altmetric:
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2020-02-04
Submitted Date
Other Titles
Abstract
Cutaneous leishmaniasis is endemic in more than 70 countries worldwide. It is a non-fatal disease caused by the Leishmania parasite that is transmitted to humans via bites of infected female sandflies. Cutaneous leishmaniasis causes skin lesions on areas of exposed skin, such as the face and limbs, which often produce scarring and atrophy. If untreated, cutaneous leishmaniasis can develop into mucocutaneous leishmaniasis, which is potentially life-threatening. Furthermore, patients with cutaneous leishmaniasis commonly experience psychosocial issues such as anxiety, distress, stigma and rejection. Cutaneous leishmaniasis is spreading outside of its traditional endemic areas because of the effects of environmental changes such as urbanisation and climate change. In the UK, healthcare professionals may encounter the disease in migrants from endemic areas, members of the armed forces, tourists and expatriates. Therefore, emergency nurses need to be able to assess and support patients who present with symptoms suggestive of cutaneous leishmaniasis. This article provides an overview of the epidemiology, aetiology, pathophysiology, clinical presentation, diagnosis, treatment and prevention of the disease.
Citation
McGhee, S., Angus, J., Finnegan, A. P., Lewis-Pierre, L., & Ortega, J. (2020). Assessment and treatment of cutaneous leishmaniasis in the emergency department. Emergency Nurse, 28(2), 23-29. https://doi.org/10.7748/en.2020.e1993
Publisher
RCN Publishing
Journal
Emergency Nurse
Research Unit
PubMed ID
PubMed Central ID
Type
Article
Language
Description
Series/Report no.
ISSN
EISSN
2047-8984
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
Embedded videos